We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

American CryoStem Licenses its ATGRAFT Technologies with HIT

News   Jul 02, 2014

 
American CryoStem Licenses its ATGRAFT Technologies with HIT
 
 
Advertisement
 

RELATED ARTICLES

Human ES Cell-derived Hepatocytes Successfully Transplanted Into Humans

News

In a recent clinical trial, ES cell-derived hepatocytes were transplanted into a six day old baby with congenital urea cycle disorder as a "bridge treatment" until the baby was old enough to undergo a liver transplant.

READ MORE

Epigenetic Mechanisms of Blood Cell Differentiation

News

Researchers have shown that the correct dosage of the enzyme MOF, an epigenetic regulator, can have a significant influence on blood stem cell fate.

READ MORE

Clinical Trial Shows Topical Stem Cell Treatment Leads to Hair Regrowth in Common Type of Baldness

News

The results of a new clinical trial published in the journal STEM CELLS Translational Medicine demonstrate how a topical solution made up of stem cells leads to the regrowth of hair for people with a common type of baldness.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE